Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-01-06 @ 7:06 PM
Study NCT ID:
NCT02625194
Status:
COMPLETED
Last Update Posted:
2019-07-09
First Post:
2015-11-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Utility of Oxygen Insufflation During Flexible Fiberoptic Bronchoscope-guided Intubation
Sponsor:
Yonsei University
Organization:
Study Overview
Official Title:
The Utility of Oxygen Insufflation During Flexible Fiberoptic Bronchoscope-guided Intubation
Status:
COMPLETED
Status Verified Date:
2019-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study investigate the utility of continuous oxygen insufflation during fiberoptic bronchoscope-guided intubation.
One group receives oxygen via suction channel of fiberoptic bronchoscope during intubation.
The other group does not receive oxygen during fiberoptic bronchoscope-guided intubation.
Then, the velocity of deoxygenation difference of PaO2(baseline
One group receives oxygen via suction channel of fiberoptic bronchoscope during intubation.
The other group does not receive oxygen during fiberoptic bronchoscope-guided intubation.
Then, the velocity of deoxygenation difference of PaO2(baseline
Detailed Description:
Fiberoptic bronchoscope-guided intubation is a gold standard for intubation of a patient with anticipating difficult airway. This technique takes several minutes without oxygen supply, which results in hypoxia when it prolonged. If continuous supply of oxygen during procedure improve the oxygenation, we can reduce the risk of hypoxemia and increase the safety margin during procedure.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: